Phoenix, AZ (May 8, 2019) –  A Texas private equity firm announced the purchase of Axolotl Biologix, Inc. a biotechnology leader in regenerative medicine. Terms of the deal were not disclosed. With the purchase, Axolotl board member Gary Lauterbach accepted the role of Interim CEO as Phil Larson exits. Other staff, including Chief Science Officer …